Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small cell lung cancer.

M C Iannuzzi, C H Scoggin

    The American Review of Respiratory Disease
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Small cell lung cancer (SCLC) remains a fatal disease despite chemotherapy. New therapeutic strategies require a deeper understanding of SCLC

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Polygenic risk assessment reveals pleiotropy between sarcoidosis and inflammatory disorders in the context of genetic ancestry.

    Genes and immunity·2017
    Same author

    Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans.

    Genes and immunity·2012
    Same author

    A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans.

    Genes and immunity·2010
    Same author

    HLA and environmental interactions in sarcoidosis.

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2009
    Same author

    Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study.

    Genes and immunity·2007
    Same author

    Genome-wide search for sarcoidosis susceptibility genes in African Americans.

    Genes and immunity·2005
    Same journal

    Human lung lysozyme: sources and properties.

    The American review of respiratory disease·2015
    Same journal

    "Immotile-cilia" syndrome and ciliary abnormalities induced by infection and injury.

    The American review of respiratory disease·2013
    Same journal

    Adult criteria for obstructive apnea do not identify children with serious obstruction.

    The American review of respiratory disease·1993
    Same journal

    Cell adhesion molecules and the bronchial epithelium.

    The American review of respiratory disease·1993
    Same journal

    Adhesion molecules and cytokine production.

    The American review of respiratory disease·1993
    Same journal

    Molecular mechanisms mediating lymphocyte recirculation, inflammation, and metastasis formation.

    The American review of respiratory disease·1993
    See all related articles

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Small cell lung cancer (SCLC) is a predominant fatal neoplasm.
    • Current chemotherapy offers limited survival benefits, with a plateau in therapeutic progress.
    • Understanding SCLC pathophysiology is crucial for developing novel treatments and prevention strategies.

    Purpose of the Study:

    • To explore the cellular pathophysiology of SCLC.
    • To investigate the role of chromosomal abnormalities and oncogenes in SCLC development.
    • To identify potential targets for new therapeutic interventions and prevention.

    Main Methods:

    • Review of existing clinical trial data for SCLC treatment.
    • Analysis of chromosomal abnormalities associated with SCLC.

    Related Experiment Videos

  • Investigation of growth regulatory oncogenes and their role in malignancy.
  • Exploration of immune surveillance evasion by metastatic cells and antigenic modulation.
  • Examination of the genetic basis of drug resistance.

    • Main Results:

    • Current therapeutic approaches for SCLC have reached a plateau.
    • Chromosomal abnormalities are consistently associated with SCLC, offering insights into pathogenesis.
    • Identification of oncogenes has advanced understanding of malignancy.
    • Modulating cellular antigenic expression may enhance host defense against tumor cells.
    • Understanding drug resistance mechanisms can inform strategies to overcome it.

    Conclusions:

    • A deeper understanding of SCLC's cellular and molecular basis is essential for advancing treatment and prevention.
    • Targeting chromosomal abnormalities, oncogenes, and immune evasion presents promising avenues for future SCLC therapies.
    • Similar to the control of tuberculosis, a combination of scientific advancement and public health measures may lead to SCLC control.